LASSOSTAR™ Circular Mapping Catheter - Electrophysiology cardiac catheter, single-use
ARTG ID: 376512 · Johnson & Johnson Medical Pty Ltd · Biosense Webster Inc · Class III · Started October 18, 2021
Good Name: Johnson & Johnson Medical Pty Ltd - LASSOSTAR™ Circular Mapping Catheter - Electrophysiology cardiac catheter, single-use
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 376512
- Start Date
- October 18, 2021
- Effective Date
- October 18, 2021
- Country
- United States of America
- Address
- 31 Technology Drive Suite 200, Irvine, California, 92618
Indicated for multiple electrode electrophysiological recording and stimulation of the atrial region of the heart. When used in conjunction with a radiofrequency (RF) ablation catheter and a compatible multi-channel generator, the catheter can be used to facilitate ablation of cardiac arrhythmias.
Access comprehensive regulatory information for LASSOSTAR™ Circular Mapping Catheter - Electrophysiology cardiac catheter, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 376512 and sponsored by Johnson & Johnson Medical Pty Ltd, manufactured by Biosense Webster Inc in United States of America. The device registration started on October 18, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.